Mesoblast Limited

NASDAQ: MESO · Real-Time Price · USD
16.02
-0.23 (-1.42%)
At close: Aug 18, 2025, 1:41 PM

Mesoblast Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
62.56M 70.92M 60.03M 136.88M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
1.01M 1.76M 1.76M 2.08M
Other Long-Term Assets
2.1M 481K 1.68M 1.72M
Receivables
20.95M 2.28M 4.4M 4.59M
Inventory
n/a -4.32M n/a -252K
Other Current Assets
n/a 398K 413K 451K
Total Current Assets
86.46M 81.66M 69.84M 148.23M
Property-Plant & Equipment
3.84M 6.49M 9.96M 12.14M
Goodwill & Intangibles
575.74M 577.18M 578.65M 580.55M
Total Long-Term Assets
582.69M 587.76M 592.3M 596.49M
Total Assets
669.15M 669.41M 662.14M 744.72M
Account Payables
7.07M 20.14M 23.08M 19.6M
Deferred Revenue
n/a 6.4M 17.91M -55.97M
Short-Term Debt
13.86M 5.95M 5.02M 53.2M
Other Current Liabilities
49.69M 5.43M 2.19M 18.71M
Total Current Liabilities
73.24M 41.98M 51.37M 94.27M
Long-Term Debt
100.48M 102.81M 91.62M 41.05M
Other Long-Term Liabilities
13.12M 19.11M 15.02M 19.52M
Total Long-Term Liabilities
115.56M 125.59M 113.72M 69.05M
Total Liabilities
188.8M 167.58M 165.1M 163.32M
Total Debt
118.92M 116.5M 106.91M 105.5M
Common Stock
1.31B 1.25B 1.17B 1.16B
Retained Earnings
-908.76M -820.8M -738.92M -647.57M
Comprehensive Income
78.3M 73.52M 70.65M 65.81M
Shareholders Equity
480.36M 501.84M 497.04M 581.4M
Total Investments
1.01M 1.76M 1.76M 2.08M